NKTR Drug delivery Company Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NKTR Drug delivery Company

NKTR 56.70

+5.1%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DewDiligence_on_SI who wrote (96)	8/22/2006 6:14:17 PM
From: Arthur Radley	Read Replies (2) of 507

I agree...EMIS is the one to watch. I did own the stock but I took a little profit after the recent bounce, but I might take another position before they release the current trial results. The Canadian company mentioned in the article is IMO a PR firm. They are running their trials in India...strange place to run an insulin trial when we have so many potential patients in Canada and the US.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next